VERACYTE INC stock forecast: up to 25.94 USD VCYT stock price prognosis


Forecast for Fri 19 Apr 2024 price 25.97

VERACYTE INC stock price forecast for further price development up to 2.00% (time horizon: 1 day) and price target of 25.94 USD. Short-term (time horizon: 2 weeks) VERACYTE INC share price prediction for 2024-04-19 with daily closed price projections

Key Facts

Symbol VCYT 

ISIN US92337F1075 

CUSIP 92337F107

Currency USD

Category Services-Medical Laboratories

Forecast price change %

Relative Strength Index (RSI)

Finance numbers

Revenue 123,064,000.0

Earnings per share -1.08

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

These forward-looking statements speak only as of the date hereof. The Merger Agreement also provides customary termination rights to each of the parties. Company BackgroundWe were incorporated in Delaware as Calderome, Inc. in August 2006. Calderome operated as an incubator until early 2008. Diagnostic surgery is risky, expensive and may not be viable for some patients. The Afirma classifier is included in most leading medical guidelines. The Prosigna test achieved Medicare coverage in 2015. In 2021, Prosigna's rate will decrease by 15% to approximately $2,134. Failure to meet the terms of the safe harbor does not render an arrangement illegal. Some of these items are unique to these suppliers and vendors. As we introduce any new test, we may experience supply issues as we ramp test volume. A specific CPT code (81554) was assigned to Envisia, effective January 1, 2021. We may experience limits on our revenue if patients decide not to use our tests. We are also required to maintain state licenses to conduct testing in our laboratories. We have received approval for the Afirma, Percepta and Envisia tests. Due to how we recognize revenue, our quarterly operating results are likely to fluctuate. We believe that PAMA and its implementing regulations are generally favorable to us. In 2016, the FDA announced that it would not be finalizing the guidance. We use standard industry billing codes, known as CPT codes, to bill for cytopathology. We may not be able to obtain these licenses on acceptable terms, if at all.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 43.40/100

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 177220
EFG Asset Management 2023-06-30 14337
A - Yarbrough Capital, LLC 2023-06-30 9796
A - OSAIC HOLDINGS, INC. 2023-06-30 17551
China Universal Asset Management Co., Ltd. 2023-06-30 949

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Pacer Funds Trust 2023-07-31 1829 Long
Prudential Jennison Blend Fund, Inc. 2023-11-30 44328 Long
SCHWAB STRATEGIC TRUST 2023-11-30 329822 Long
SCHWAB STRATEGIC TRUST 2023-11-30 39323 Long
Putnam Investment Funds 2023-11-30 103750 Long

Insider trading for VERACYTE INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1588970 Anderson Bonnie H 2023-03-15 SALE Reject Accept Accept Accept

Bollinger Bollinger Bands for VERACYTE INC can provide the information where the market is moving based on price information.

VERACYTE INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns VERACYTE INC.

On-Balance Volume information for VERACYTE INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for VERACYTE INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for VERACYTE INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for VERACYTE INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for VERACYTE INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for VERACYTE INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for VERACYTE INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

Moving Average Crossover

52W High 52W Low Market Cap

Similar shares


VERACYTE INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2024-04-18 25.94 2024-02-23 07:51
2024-04-19 25.97 2024-02-23 07:52
2024-03-21 25.21 2024-02-23 07:51
2024-03-11 24.80 2024-02-23 07:51
2024-03-12 24.75 2024-02-23 07:51
2024-03-13 25.08 2024-02-23 07:51
2024-02-26 24.36 2024-02-23 07:51
2024-02-27 24.06 2024-02-23 07:51
2024-03-14 24.97 2024-02-23 07:51
2024-03-15 25.01 2024-02-23 07:51
2024-02-29 24.27 2024-02-23 07:51
2024-03-01 24.32 2024-02-23 07:51
2024-02-28 24.60 2024-02-23 07:51
2024-03-22 25.30 2024-02-23 07:51
2024-03-25 25.36 2024-02-23 07:51
2024-03-26 25.27 2024-02-23 07:51
2024-03-27 25.43 2024-02-23 07:51
2024-04-08 25.70 2024-02-23 07:51
2024-04-09 25.68 2024-02-23 07:51
2024-03-04 24.67 2024-02-23 07:51
2024-03-05 24.66 2024-02-23 07:51
2024-03-06 24.40 2024-02-23 07:51
2024-03-07 24.81 2024-02-23 07:51
2024-03-08 24.82 2024-02-23 07:51
2024-03-18 25.09 2024-02-23 07:51
2024-03-19 25.16 2024-02-23 07:51
2024-03-20 25.14 2024-02-23 07:51
2024-04-05 25.64 2024-02-23 07:51
2024-04-10 25.74 2024-02-23 07:51
2024-03-28 25.46 2024-02-23 07:51
2024-04-01 25.47 2024-02-23 07:51
2024-04-02 25.58 2024-02-23 07:51
2024-04-03 25.55 2024-02-23 07:51
2024-03-29 25.43 2024-02-23 07:51
2024-04-11 25.79 2024-02-23 07:51
2024-04-15 25.83 2024-02-23 07:51
2024-04-16 25.89 2024-02-23 07:51
2024-04-17 25.92 2024-02-23 07:51
2024-04-04 25.59 2024-02-23 07:51
2024-04-12 25.81 2024-02-23 07:51

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.